Capability details
Cellanyx leverages advances in matrix biology, nanomedicine, and classical techniques in engineering, computer science and mathematics to provide a sensitive, objective and predictive solution to cancer diagnosis. Patients who are diagnosed with prostate, skin, and breast cancer, are being monitored and/or are surgical candidates will benefit from the technology. The test ordered (at diagnosis) can provide physicians with objective prognostic information to assist in their treatment decision process.